List of Tables
Table 1. Global Meloxicam Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Meloxicam Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Meloxicam Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Meloxicam Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Meloxicam Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Meloxicam Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Meloxicam Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Meloxicam Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Meloxicam Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Meloxicam Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Meloxicam Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Meloxicam Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meloxicam Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Meloxicam Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meloxicam Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Meloxicam Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Meloxicam Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Meloxicam Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Meloxicam Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Meloxicam Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Meloxicam Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Meloxicam Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Meloxicam Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Meloxicam Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Meloxicam Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Meloxicam Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Meloxicam Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Meloxicam Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Meloxicam Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Meloxicam Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Meloxicam Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Meloxicam Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Meloxicam Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Meloxicam Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Meloxicam Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Meloxicam Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Meloxicam Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Meloxicam Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Meloxicam Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Meloxicam Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Meloxicam Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Meloxicam Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Meloxicam Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Meloxicam Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Meloxicam Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Meloxicam Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Meloxicam Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Meloxicam Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Meloxicam Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Meloxicam Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Meloxicam Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Meloxicam Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Meloxicam Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Meloxicam Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Meloxicam Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Meloxicam Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Meloxicam Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Meloxicam Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Meloxicam Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Meloxicam Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Meloxicam Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Meloxicam Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Meloxicam Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Meloxicam Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Meloxicam Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Meloxicam Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Meloxicam Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Meloxicam Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Boehringer Ingelheim Meloxicam Drugs Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Iroko Pharmaceuticals Company Information
Table 76. Iroko Pharmaceuticals Description and Business Overview
Table 77. Iroko Pharmaceuticals Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Iroko Pharmaceuticals Meloxicam Drugs Product
Table 79. Iroko Pharmaceuticals Recent Developments/Updates
Table 80. Lupin Company Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Lupin Meloxicam Drugs Product
Table 84. Lupin Recent Developments/Updates
Table 85. Novitium Pharma Company Information
Table 86. Novitium Pharma Description and Business Overview
Table 87. Novitium Pharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novitium Pharma Meloxicam Drugs Product
Table 89. Novitium Pharma Recent Developments/Updates
Table 90. Zydus Company Information
Table 91. Zydus Description and Business Overview
Table 92. Zydus Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Zydus Meloxicam Drugs Product
Table 94. Zydus Recent Developments/Updates
Table 95. Nipro Company Information
Table 96. Nipro Description and Business Overview
Table 97. Nipro Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Nipro Meloxicam Drugs Product
Table 99. Nipro Recent Developments/Updates
Table 100. Luye Pharma Company Information
Table 101. Luye Pharma Description and Business Overview
Table 102. Luye Pharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Luye Pharma Meloxicam Drugs Product
Table 104. Luye Pharma Recent Developments/Updates
Table 105. Simcere Pharmaceutical Company Information
Table 106. Simcere Pharmaceutical Description and Business Overview
Table 107. Simcere Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Simcere Pharmaceutical Meloxicam Drugs Product
Table 109. Simcere Pharmaceutical Recent Developments/Updates
Table 110. Kelun Pharmaceutical Company Information
Table 111. Kelun Pharmaceutical Description and Business Overview
Table 112. Kelun Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kelun Pharmaceutical Meloxicam Drugs Product
Table 114. Kelun Pharmaceutical Recent Developments/Updates
Table 115. YaoPharma Company Information
Table 116. YaoPharma Description and Business Overview
Table 117. YaoPharma Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. YaoPharma Meloxicam Drugs Product
Table 119. YaoPharma Recent Developments/Updates
Table 120. Yangtze River Pharmaceutical Company Information
Table 121. Yangtze River Pharmaceutical Description and Business Overview
Table 122. Yangtze River Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Yangtze River Pharmaceutical Meloxicam Drugs Product
Table 124. Yangtze River Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Xianju Pharmaceutical Company Information
Table 126. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 127. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product
Table 129. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 130. Qilu Pharmaceutical Company Information
Table 131. Qilu Pharmaceutical Description and Business Overview
Table 132. Qilu Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Qilu Pharmaceutical Meloxicam Drugs Product
Table 134. Qilu Pharmaceutical Recent Developments/Updates
Table 135. Jiangsu Jibeier Pharmaceutical Company Information
Table 136. Jiangsu Jibeier Pharmaceutical Description and Business Overview
Table 137. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product
Table 139. Jiangsu Jibeier Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Meloxicam Drugs Distributors List
Table 143. Meloxicam Drugs Customers List
Table 144. Meloxicam Drugs Market Trends
Table 145. Meloxicam Drugs Market Drivers
Table 146. Meloxicam Drugs Market Challenges
Table 147. Meloxicam Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meloxicam Drugs
Figure 2. Global Meloxicam Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Meloxicam Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Preparations Product Picture
Figure 5. Topical Preparations Product Picture
Figure 6. Injections Product Picture
Figure 7. Global Meloxicam Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Meloxicam Drugs Market Share by Application: 2025 & 2032
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Online Pharmacy
Figure 12. Global Meloxicam Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Meloxicam Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Meloxicam Drugs Sales (K Units), 2021–2032
Figure 15. Global Meloxicam Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Meloxicam Drugs Report Years Considered
Figure 17. Meloxicam Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Meloxicam Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Meloxicam Drugs Players: Market Share by Revenue in Meloxicam Drugs in 2025
Figure 20. Meloxicam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Meloxicam Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Meloxicam Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Meloxicam Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Meloxicam Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Meloxicam Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Meloxicam Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Meloxicam Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Meloxicam Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Meloxicam Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Meloxicam Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Meloxicam Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Meloxicam Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Meloxicam Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Meloxicam Drugs by Type (2021–2032)
Figure 55. Global Meloxicam Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Meloxicam Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Meloxicam Drugs by Application (2021–2032)
Figure 58. Global Meloxicam Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Meloxicam Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
